Accessibility Menu
 
Athersys logo

Athersys

(OTC) ATHX

Current PriceN/A
Market CapN/A
Since IPO (2007)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Athersys Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$80.00K

Net Income (TTM)

$37.51M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ATHX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Athersys

Industry

Biotechnology

Employees

24

CEO

Daniel A. Camardo, MBA

Headquarters

Cleveland, OH 44115-2634, US

ATHX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-14%

Net Income Margin

-13%

Return on Equity

18%

Return on Capital

5%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$5.33M

Operating Income

$77.01M

EBITDA

$75.59M

Operating Cash Flow

$58.95M

Capital Expenditure

$397.00K

Free Cash Flow

$59.35M

Cash & ST Invst.

$9.04M

Total Debt

$8.69M

Athersys Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

24

N/A

Net Income

$3.77M

+72.4%

EBITDA

$6.80M

+57.7%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$17.56M

-463.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$18.58M

+2098.5%

Return on Assets

-2.45%

N/A

Return on Invested Capital

5.26%

N/A

Free Cash Flow

$3.85M

+63.7%

Operating Cash Flow

$3.85M

+63.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMPLImpel Pharmaceuticals Inc.
$0.04-27.27%
INFIQInfinity Pharmaceuticals, Inc.
$0.00+0.00%
BLCMBellicum Pharmaceuticals, Inc.
$0.07-6.68%
ACORAcorda Therapeutics, Inc.
$0.66-24.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About ATHX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.